Your browser doesn't support javascript.
loading
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review.
Layard Horsfall, Hugo; Lawrence, Alistair; Venkatesh, Ashwin; Loh, Ryan T S; Jayapalan, Ronie; Koulouri, Olympia; Sharma, Rishi; Santarius, Thomas; Gurnell, Mark; Dorward, Neil; Mannion, Richard; Marcus, Hani J; Kolias, Angelos G.
Affiliation
  • Layard Horsfall H; Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. hugo.layardhorsfall@ucl.ac.uk.
  • Lawrence A; Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, Queen Square, London, W1CN 3BG, UK. hugo.layardhorsfall@ucl.ac.uk.
  • Venkatesh A; Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London, London, UK. hugo.layardhorsfall@ucl.ac.uk.
  • Loh RTS; Department of Neurosurgery, Royal London Hospital, London, UK.
  • Jayapalan R; Clinical School of Medicine, University of Cambridge, Cambridge, UK.
  • Koulouri O; Clinical School of Medicine, University of Cambridge, Cambridge, UK.
  • Sharma R; Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Santarius T; Metabolic Research Laboratories, Institute of Metabolic Science and Department of Medicine, University of Cambridge and Addenbrooke's Hospital, Cambridge, UK.
  • Gurnell M; Department of Otolaryngology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Dorward N; Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Mannion R; Metabolic Research Laboratories, Institute of Metabolic Science and Department of Medicine, University of Cambridge and Addenbrooke's Hospital, Cambridge, UK.
  • Marcus HJ; Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, Queen Square, London, W1CN 3BG, UK.
  • Kolias AG; Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Pituitary ; 26(2): 171-181, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36862265
ABSTRACT

PURPOSE:

Transsphenoidal surgery is an established treatment for pituitary adenomas. We examined outcomes and time points following transsphenoidal surgery for pituitary adenoma to identify reporting heterogeneity within the literature.

METHODS:

A systematic review of studies that reported outcomes for transsphenoidal surgery for pituitary adenoma 1990-2021 were examined. The protocol was registered a priori and adhered to the PRISMA statement. Studies in English with > 10 patients (prospective) or > 500 patients (retrospective) were included.

RESULTS:

178 studies comprising 427,659 patients were included. 91 studies reported 2 or more adenoma pathologies within the same study; 53 studies reported a single pathology. The most common adenomas reported were growth hormone-secreting (n = 106), non-functioning (n = 101), and ACTH-secreting (n = 95); 27 studies did not state a pathology. Surgical complications were the most reported outcome (n = 116, 65%). Other domains included endocrine (n = 104, 58%), extent of resection (n = 81, 46%), ophthalmic (n = 66, 37%), recurrence (n = 49, 28%), quality of life (n = 25, 19%); and nasal (n = 18, 10%). Defined follow up time points were most reported for endocrine (n = 56, 31%), extent of resection (n = 39, 22%), and recurrence (n = 28, 17%). There was heterogeneity in the follow up reported for all outcomes at different time points discharge (n = 9), < 30 days (n = 23), < 6 months (n = 64), < 1 year (n = 23), and > 1 year (n = 69).

CONCLUSION:

Outcomes and follow up reported for transsphenoidal surgical resection of pituitary adenoma are heterogenous over the last 30 years. This study highlights the necessity to develop a robust, consensus-based, minimum, core outcome set. The next step is to develop a Delphi survey of essential outcomes, followed by a consensus meeting of interdisciplinary experts. Patient representatives should also be included. An agreed core outcome set will enable homogeneous reporting and meaningful research synthesis, ultimately improving patient care.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma Type of study: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma Type of study: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Year: 2023 Type: Article